Tandem Diabetes Care reported $-0.3 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 -0.20 -0.31 Nov/04
FY2026Q2 Jun/2026 -0.33 -0.78 Aug/06
FY2026Q1 Mar/2026 -0.30 -0.44 -1.97 May/07
FY2025Q4 Dec/2025 -0.01 -0.09 0.01 Feb/19
FY2025Q3 Sep/2025 -0.31 -0.33 -0.35 Nov/06




Eps Change Date
Abbott USD 1.31 0.16 Jun/2026
Accuray USD 0.02 0.06 Dec/2024
Align Technology USD 2.64 0.06 Jun/2026
AtriCure USD 0.18 0.18 Jun/2026
Baxter International USD 0.56 0.2 Jun/2026
Becton, Dickinson and Co. USD 2.9 0.01 Mar/2026
Boston Scientific USD 0.86 0.06 Jun/2026
Cooper Companies USD 1.04 0.38 Mar/2026
Dexcom USD 0.7 0.14 Jun/2026
Edwards Lifesciences USD 0.78 0 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Globus Medical USD 1.12 0.16 Mar/2026
ICU Medical USD 1.97 0.06 Mar/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.66 0.24 Jun/2026
Integra LifeSciences USD 0.56 0.02 Jun/2026
Intuitive Surgical USD 2.8 0.3 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Medtronic USD 1.55 0.19 Mar/2026
Merit Medical Systems USD 1.19 0.33 Jun/2026
Orthofix International USD 0.08 0.12 Dec/2025
Roche Holding CHF 10.98 2.61 Jun/2026
Stryker USD 3.69 1.09 Jun/2026
Tandem Diabetes Care USD -0.3 0.29 Mar/2026
Teleflex USD 1.39 0.54 Mar/2026
Zimmer Biomet Holdings USD 2.07 0.02 Jun/2026